Drug profile · INN
oseltamivir
EBILFUMIN
oseltamivir (EBILFUMIN) is an FDA-listed pharmaceutical active ingredient.
EMA: approved NMPA: clinical trials Antiinfectives for systemic use (J05) J05AH02
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — oseltamivir
- Class
- Antiinfectives for systemic use (J05)
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.83
Quick answer
oseltamivir (EBILFUMIN) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN oseltamivir
Brand EBILFUMIN
Therapeutic class Antiinfectives for systemic use (J05)
ATC code J05AH02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is oseltamivir?
oseltamivir (EBILFUMIN) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for oseltamivir?
EBILFUMIN is a marketed brand name for oseltamivir. Check FDA Drugs@FDA for the current US label holder and prescribing information.